CBT-I as First-Line Treatment for Chronic Insomnia
Cognitive behavioral therapy for insomnia (CBT-I) should be delivered as a multicomponent therapy over 4-8 sessions, combining sleep restriction therapy, stimulus control instructions, cognitive therapy, and sleep hygiene education, with treatment progress guided by patient-completed sleep diaries.
Treatment Structure and Components
The American Academy of Sleep Medicine 1 and American College of Physicians 2 both provide strong recommendations for CBT-I as first-line treatment. Here's the specific course structure:
Standard CBT-I Course (Preferred)
- Duration: 4-8 sessions (typically 6-8 sessions) 1, 3
- Format: Can be delivered in-person, digitally, via telehealth, group therapy, or self-help modules 2, 4
Core Components That Must Be Included:
Behavioral interventions (the foundation):
- Sleep restriction therapy: Limit time in bed to match actual sleep duration from sleep diaries, then adjust based on sleep efficiency thresholds 1
- Stimulus control instructions: Five specific rules:
- Go to bed only when sleepy
- Get out of bed when unable to sleep
- Use bed/bedroom for sleep and sex only
- Wake at the same time every morning
- No daytime napping 1
Cognitive therapy: Structured psychoeducation and Socratic questioning to identify and modify unhelpful beliefs about sleep 1
Sleep hygiene education: Lifestyle and environmental factors affecting sleep 1
Sleep diaries: Patients complete these throughout treatment to guide adjustments 1
Alternative: Brief Behavioral Therapy for Insomnia (BTI)
If standard CBT-I is not feasible, the AASM conditionally recommends BTI 1:
- Duration: 1-4 sessions (abbreviated version)
- Components: Emphasizes behavioral elements (sleep restriction and stimulus control) with brief relaxation or cognitive elements
- When to use: When patients prefer brief treatment or resources are limited
Critical Safety Considerations
Contraindications for sleep restriction therapy component 1:
- High-risk occupations (heavy machinery operators, drivers)
- Patients predisposed to mania/hypomania
- Poorly controlled seizure disorders
Expected transient effects 1:
- Daytime sleepiness and fatigue may occur early in treatment when behavioral therapies are introduced
- These effects typically resolve by end of treatment
- Benefits strongly outweigh these short-term effects
Efficacy and Outcomes
- Up to 80% of patients achieve clinically relevant improvements 6
- Superior long-term effectiveness compared to medications 1
- Sustained improvements even with psychiatric or medical comorbidities 6, 5
- Effective across all adult age groups, including older adults 2
When CBT-I Alone Is Insufficient
Only after CBT-I has been tried, consider adding short-term pharmacotherapy (≤4 weeks) through shared decision-making 2, 5:
- Benzodiazepines or benzodiazepine receptor agonists
- Orexin receptor antagonists (can extend to 3 months)
- Low-dose sedating antidepressants
- Prolonged-release melatonin (patients ≥55 years, up to 3 months)
Not recommended: Antihistamines, antipsychotics, fast-release melatonin, ramelteon, or phytotherapeutics 5
Implementation Barriers to Avoid
The most recent evidence 7 identifies common pitfalls in clinical practice:
- Limited clinician knowledge about CBT-I components
- Patient expectations for immediate pharmacological solutions
- Incorrectly identifying benzodiazepines as first-line treatment (48% of surveyed clinicians made this error)
- Time constraints leading to medication-first approaches
The evidence is unequivocal: CBT-I has strong, high-quality evidence supporting 4-8 sessions as the standard course, with BTI (1-4 sessions) as a conditional alternative when standard CBT-I is not feasible 1, 2, 5.